These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 14680975)

  • 1. Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.
    Eurlings PM; van der Kallen CJ; Vermeulen VM; de Bruin TW
    Mol Genet Metab; 2003 Nov; 80(3):296-301. PubMed ID: 14680975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
    Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients.
    Ylitalo K; Nuotio I; Viikari J; Auwerx J; Vidal H; Taskinen MR
    Metabolism; 2002 May; 51(5):664-70. PubMed ID: 11979403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia.
    Nanni L; Quagliarini F; Megiorni F; Montali A; Minicocci I; Campagna F; Pizzuti A; Arca M
    Atherosclerosis; 2010 Nov; 213(1):206-11. PubMed ID: 20832801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
    Reynisdottir S; Eriksson M; Angelin B; Arner P
    J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.
    Eurlings PM; van der Kallen CJ; Geurts JM; Flavell DM; de Bruin TW
    Mol Genet Metab; 2002 Dec; 77(4):274-81. PubMed ID: 12468272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.
    Castro Cabezas M; de Bruin TW; de Valk HW; Shoulders CC; Jansen H; Willem Erkelens D
    J Clin Invest; 1993 Jul; 92(1):160-8. PubMed ID: 8100834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus.
    van der Kallen CJ; Voors-Pette C; Bouwman FG; Keizer HA; Lu JY; van de Hulst RR; Bianchi R; Janssen MJ; Keulen ET; Boeckx WD; Rotter JI; de Bruin TW
    Atherosclerosis; 2002 Oct; 164(2):337-46. PubMed ID: 12204806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of CD36/FAT in preadipocytes in familial combined hyperlipidemia.
    Meex SJ; van der Kallen CJ; van Greevenbroek MM; Eurlings PM; El Hasnaoui M; Evelo CT; Lindsey PJ; Luiken JJ; Glatz JF; de Bruin TW
    FASEB J; 2005 Dec; 19(14):2063-5. PubMed ID: 16219805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia.
    Pihlajamäki J; Miettinen R; Valve R; Karjalainen L; Mykkänen L; Kuusisto J; Deeb S; Auwerx J; Laakso M
    Atherosclerosis; 2000 Aug; 151(2):567-74. PubMed ID: 10924736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
    Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
    Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveling the complex genetics of familial combined hyperlipidemia.
    Suviolahti E; Lilja HE; Pajukanta P
    Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia.
    Halkes CJ; van Dijk H; Verseyden C; de Jaegere PP; Plokker HW; Meijssen S; Erkelens DW; Cabezas MC
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1875-80. PubMed ID: 12933534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic dissection of familial combined hyperlipidemia.
    Eurlings PM; van der Kallen CJ; Geurts JM; van Greevenbroek MM; de Bruin TW
    Mol Genet Metab; 2001; 74(1-2):98-104. PubMed ID: 11592807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families.
    Huertas-Vázquez A; del Rincón JP; Canizales-Quinteros S; Riba L; Vega-Hernández G; Ramírez-Jiménez S; Aurón-Gómez M; Gómez-Pérez FJ; Aguilar-Salinas CA; Tusié-Luna MT
    Ann Hum Genet; 2004 Sep; 68(Pt 5):419-27. PubMed ID: 15469419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia.
    Morello F; de Bruin TW; Rotter JI; Pratt RE; van der Kallen CJ; Hladik GA; Dzau VJ; Liew CC; Chen YD
    Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2149-54. PubMed ID: 15388524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.
    Brouwers MC; de Graaf J; van Greevenbroek MM; Schaper N; Stehouwer CD; Stalenhoef AF
    Curr Opin Lipidol; 2010 Dec; 21(6):530-8. PubMed ID: 20739883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal obesity and expression of familial combined hyperlipidemia.
    van der Kallen CJ; Voors-Pette C; de Bruin TW
    Obes Res; 2004 Dec; 12(12):2054-61. PubMed ID: 15687407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia.
    Pihlajamäki J; Rissanen J; Heikkinen S; Karjalainen L; Laakso M
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1039-44. PubMed ID: 9194752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E.
    Brouwers MC; Govers-Riemslag J; Schalkwijk CG; van Greevenbroek MM; van der Kallen CJ; Bekers O; van Dieijen-Visser MP; Ten Oever J; Bilderbeek-Beckers MA; de Bruin TW; Ten Cate H; Stehouwer CD
    Thromb Res; 2008; 122(4):466-72. PubMed ID: 18262228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.